AK Medical Holdings Ltd. (HK:1789)
:1789
Want to see HK:1789 full AI Analyst Report?
Total Valuation
AK Medical Holdings Ltd. has a market cap or net worth of HK$6.81B. The enterprise value is HK$5.62B.
Market CapHK$6.81B
Enterprise ValueHK$5.62B
Share Statistics
AK Medical Holdings Ltd. has 1,123,920,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,123,920,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AK Medical Holdings Ltd.’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 10.22%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)10.22%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee1.56M
Profits Per Employee347.70K
Employee Count950
Asset Turnover0.40
Inventory Turnover1.27
Valuation Ratios
The current PE Ratio of AK Medical Holdings Ltd. is 16.9. AK Medical Holdings Ltd.’s PEG ratio is 0.84.
PE Ratio16.9
PS Ratio3.87
PB Ratio1.97
Price to Fair Value1.97
Price to FCF18.13
Price to Operating Cash Flow25.97
PEG Ratio0.84
Income Statement
In the last 12 months, AK Medical Holdings Ltd. had revenue of 1.48B and earned 339.09M in profits. Earnings per share was 0.30.
Revenue1.48B
Gross Profit897.39M
Operating Income373.88M
Pretax Income394.98M
Net Income339.09M
EBITDA465.33M
Earnings Per Share (EPS)0.30
Cash Flow
In the last 12 months, operating cash flow was 226.76M and capital expenditures -29.98M, giving a free cash flow of 196.78M billion.
Operating Cash Flow226.76M
Free Cash Flow196.78M
Free Cash Flow per Share0.18
Dividends & Yields
AK Medical Holdings Ltd. pays an annual dividend of HK$0.072, resulting in a dividend yield of 1.26%
Dividend Per ShareHK$0.072
Dividend Yield1.26%
Payout Ratio25.03%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.04
52-Week Price Change5.02%
50-Day Moving Average6.34
200-Day Moving Average6.04
Relative Strength Index (RSI)37.87
Average Volume (3m)4.30M
Important Dates
AK Medical Holdings Ltd. upcoming earnings date is Sep 2, 2026, TBA (Confirmed).
Last Earnings DateMar 25, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
AK Medical Holdings Ltd. as a current ratio of 4.10, with Debt / Equity ratio of 4.97%
Current Ratio4.10
Quick Ratio3.41
Debt to Market Cap0.02
Net Debt to EBITDA-0.49
Interest Coverage Ratio127.13
Taxes
In the past 12 months, AK Medical Holdings Ltd. has paid 55.88M in taxes.
Income Tax55.88M
Effective Tax Rate0.14
Enterprise Valuation
AK Medical Holdings Ltd. EV to EBITDA ratio is 11.82, with an EV/FCF ratio of 17.40.
EV to Sales3.71
EV to EBITDA11.82
EV to Free Cash Flow17.40
EV to Operating Cash Flow13.12
Balance Sheet
AK Medical Holdings Ltd. has HK$1.47B in cash and marketable securities with HK$144.79M in debt, giving a net cash position of HK$1.32B billion.
Cash & Marketable SecuritiesHK$1.47B
Total DebtHK$144.79M
Net CashHK$1.32B
Net Cash Per ShareHK$1.18
Tangible Book Value Per ShareHK$2.43
Margins
Gross margin is 60.54%, with operating margin of 25.22%, and net profit margin of 22.87%.
Gross Margin60.54%
Operating Margin25.22%
Pretax Margin26.64%
Net Profit Margin22.87%
EBITDA Margin31.39%
EBIT Margin25.22%
Analyst Forecast
The average price target for AK Medical Holdings Ltd. is HK$8.08, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$8.08
Price Target Upside36.79% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast10.19%
EPS Growth Forecast23.70%